The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001.
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Peerview
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; iOMEDICO; Janssen Research & Development; Juno Therapeutics; More Health; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Janssen Research & Development; Juno Therapeutics; Karus Therapeutics; Kite, a Gilead company; Novartis; Oncternal Therapeutics; Pharmacyclics
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Leo I. Gordon
Consulting or Advisory Role - Bayer; Gilead Sciences; Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Zylem
 
Maria Lia Palomba
Stock and Other Ownership Interests - Seres Therapeutics (I)
Honoraria - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Merck; Merck (I); Novartis (I); Pharmacyclics; Seres Therapeutics (I); Therakos (I)
Consulting or Advisory Role - Amgen (I); Celgene; Evelo Therapeutics (I); Flagship Biosciences (I); Jazz Pharmaceuticals (I); Merck; Merck (I); Novartis (I); Seres Therapeutics (I); Therakos (I)
Research Funding - Seres Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Intellectual Property Rights (I); Juno intellectual property rights (Inst)
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; Novartis; Seagen; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); genentech (Inst); Juno Therapeutics (Inst); Seagen (Inst)
 
Charalambos Andreadis
Employment - Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Celgene; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis; Pharmacyclics; Seagen; Spectrum Pharmaceuticals
Research Funding - Amgen; Cellerant; GlaxoSmithKline; Juno Therapeutics; Karyopharm Therapeutics; Novartis
 
Nilanjan Ghosh
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Kite/Gilead; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bayer; Celgene; Genentech; Genzyme; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Kite, a Gilead company; Novartis; Pharmacyclics; Portola Pharmaceuticals; Seagen; Spectrum Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Curis (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); miRagen (Inst); TG Therapeutics (Inst); TG Therapeutics (Inst)
 
David G. Maloney
Consulting or Advisory Role - Celgene; Eureka Therapeutics; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.
 
Thalia Andrea Farazi
Employment - Juno/Celgene
Stock and Other Ownership Interests - Juno/Celgene
 
Jacob Garcia
Employment - Juno/Celgene
Stock and Other Ownership Interests - Amgen; Celgene
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Travel, Accommodations, Expenses - Celgene
 
Benhuai Xie
Employment - Juno Therapeutics; Seagen (I)
Stock and Other Ownership Interests - Juno Therapeutics; Seagen (I)
 
Kathryn J. Newhall
Employment - Celgene
Stock and Other Ownership Interests - Amgen; Celgene
Travel, Accommodations, Expenses - Celgene
 
Christine Dehner
Employment - Juno/Celgene
Stock and Other Ownership Interests - Juno/Celgene
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics